National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
386 enrolled
ADVICE
Phase 1/2 Recruiting
80 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
MOMENTUM
Recruiting
8,000 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
DP-04
Recruiting
100 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
GUARDIAN-101
Phase 1 Recruiting
90 enrolled
EXCEED
Phase 1 Recruiting
490 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
ID-COMET
Phase 3 Recruiting
800 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
iCaRe2
Recruiting
999,999 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
51 enrolled
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Phase NA Recruiting
80 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
CAMPERR
Recruiting
7,000 enrolled
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Phase NA Recruiting
50 enrolled
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
145 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/2 Recruiting
27 enrolled
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Phase 1/2 Recruiting
862 enrolled
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
Recruiting
200 enrolled
Stereotactic Magnetic Resonance Guided Radiation Therapy
Phase NA Recruiting
397 enrolled
EXCEL
Phase NA Recruiting
740 enrolled
RCT-SE
Phase NA Recruiting
400 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
FASCINATE
Phase NA Recruiting
100 enrolled
A Study of Mental Health Care in People With Cancer
Phase NA Recruiting
130 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
INSPIRE
Recruiting
5,350 enrolled
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
Phase 1 Recruiting
36 enrolled
MOHCCN-O
Recruiting
500 enrolled
COACH
Phase NA Recruiting
625 enrolled
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Phase 1 Recruiting
33 enrolled
The Impact of Radiotherapy on Oligometastatic Cancer
Recruiting
2,000 enrolled
CER
Recruiting
15,000 enrolled